Origin Therapeutics Holdings Inc. (ORIG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,562 | 2,822 | 2,901 | 3,043 | 3,310 |
| Marketable Securities | 504 | 505 | 2,162 | 2,187 | 2,513 |
| Receivables | 71 | 43 | 64 | 52 | 295 |
| TOTAL | $3,191 | $3,369 | $5,133 | $5,314 | $6,178 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 271 | 274 | N/A |
| TOTAL | $0 | $0 | $271 | $274 | $0 |
| Total Assets | $3,191 | $3,369 | $5,404 | $5,588 | $6,178 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50 | 164 | 45 | 84 | 124 |
| TOTAL | $110 | $224 | $105 | $159 | $199 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $110 | $224 | $105 | $159 | $199 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,563 | N/A | N/A | N/A | N/A |
| Common Shares | 6,955 | 6,955 | 6,955 | 6,955 | 6,955 |
| Retained earnings | -4,643 | -4,201 | -2,425 | -2,295 | -1,746 |
| Other shareholders' equity | 769 | 392 | 769 | 769 | 769 |
| TOTAL | $3,081 | $3,145 | $5,299 | $5,429 | $5,978 |
| Total Liabilities And Equity | $3,191 | $3,369 | $5,404 | $5,588 | $6,178 |